Episode Summary
Executive Summary: Michael Shermer interviews cyclist and women’s sports advocate Inga Thompson about the history and ethics of sex categories in sport, focusing on transgender participation in women’s events. Thompson argues that biological sex creates enduring athletic advantages that testosterone suppression cannot erase, and she calls for separate women’s and transgender categories, plus broader protection of female sports and spaces.
Main Topics: Women’s sports and sex-separated competition: Thompson argues that women’s categories exist to preserve fairness because biological males retain advantages in strength, endurance, bone structure, and physiology even after transition or hormone suppression. Historical roots of gender ideology in sport: The conversation traces modern sex/gender ideas back to John Money, the Reimer twins, and later changes in Olympic gender verification, framing today’s disputes as the result of a long ideological shift. Transgender inclusion vs fairness and category design: Both speakers explore the possibility of a separate transgender category or open category, rather than placing trans women in women’s divisions, as a compromise between inclusion and competitive equity. Doping, performance enhancement, and athletic arms races: The discussion compares transgender advantage debates to doping in cycling, EPO, blood doping, and performance-enhancing drugs, emphasizing how incentives and weak enforcement distort competition. Cancellation, institutional pressure, and free speech: Thompson describes backlash from cycling organizations and media, arguing that people who question current policies are smeared or silenced, while Shermer notes pluralistic ignorance and cancel culture dynamics. Personal athletic experience and mentorship: Thompson reflects on her own career, training, role models, and the importance of perseverance, coaching, and disciplined work for young athletes and leaders. Breast cancer, medicine, and medical decision-making: Thompson uses her cancer treatment and mastectomy experience to criticize standard medical protocols and draw parallels to youth gender medicine, puberty blockers, and long-term drug dependence.
Key Arguments: Biological sex matters in sport because males retain advantages that hormone suppression does not eliminate, including bone size, heart size, oxygen capacity, and power output. True transgender people are rare, but self-ID and autogynephilia can open sports to men seeking validation rather than fair competition. The fairest solution is separate categories: women’s categories for biological women and a distinct transgender/open category for others. Doping in cycling shows how competition becomes distorted when rules are weak or unenforced; trans inclusion in women’s sport creates a similar fairness problem. Athletes, especially younger ones, should not bear the main burden of public resistance; team owners, governing bodies, parents, and coaches should act instead. Puberty blockers and related youth gender interventions are presented as irreversible or highly consequential, making 'watchful waiting' preferable according to Thompson. Media and sports institutions are politically biased in favor of trans inclusion and often ignore women’s concerns or data showing opposition among female athletes. Women’s sports should be valued on their own terms, not measured against men’s sports, and should remain protected to sustain grassroots participation.
Data Points: Olympic Games competed: 3 - Inga Thompson competed at the 1984, 1988, and 1992 Olympic Games. Best Olympic finish: 8th place - Thompson’s best Olympic result was eighth in 1988. World Championship silver medals: 3 - She won silver medals in 1987, 1990, and 1991. Tour de France placings: 3rd place in 1986 and 1989 - Mentioned as part of Thompson’s career accomplishments. U.S. National Road Race Championships: 5 wins - She reportedly won in 1987, 1988, 1991, 1993, and 1999. Olympians petition signatures: 80+ - Thompson says she obtained signatures on a petition to the IOC limiting women’s categories to cisgender women. Peer-reviewed studies cited: 22 - Thompson cites studies claiming testosterone suppression does not remove male athletic advantage. 93%: 93% of professional women cyclists - She says a survey found 93% did not want transgender women in their sport. Cancer detection timing: 7-8 years - Thompson said she had gone without an exam for about seven or eight years before cancer was found. Heart rate operating range: 190-195 bpm - Thompson described being most efficient at a high cycling heart rate in this range. Hematocrit: 46-47% - Thompson said her natural hematocrit was around this level, near the upper healthy range. Blood doping/hematocrit limit: 50% limit referenced - Shermer discussed anti-doping rules and hematocrit thresholds in cycling. Estimated athletic advantage: 10-30% - Thompson estimates male advantage persists after testosterone suppression, varying by sport. Youth opposition age window: 8-10 years old - She claimed many girls leave sport if not given sex-separated competition at this age. Puberty suppression claim: 'forever paused' - Thompson argues blockers do not merely pause puberty but can cause lasting developmental harm.
Pivotal Quotes: "women are not small, weaker men. We are women." — Inga Thompson: Thompson summarizes her central argument about biological sex and athletic fairness. "The new Omerta is thou shalt not speak of gender doping" — Inga Thompson: She compares silence around transgender sports policy to cycling’s former code of silence about doping. "This should be a human rights issue discussion for equality for women." — Michael Shermer: Shermer frames the debate as a conflict between inclusion and women’s rights, not partisan politics.
Implications: The episode argues that sports governing bodies face a legitimacy crisis unless they address sex-based fairness, protect women’s categories, and create alternative divisions for transgender athletes. It also suggests the debate will shape media, politics, youth sports, and medical policy.